20 September, 2022

Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia

From September 22nd to September 24th, Hyris will be present at the SEI 2022 in Leon, to show the scientific approach related to our new T Cells test to monitor the cellular immunity to SARS-CoV-2.

On September 22nd at 1pm our Product Specialist Matteo Audano will hold a talk at the dedicated symposium titled "Development of a PCR diagnostic test to monitor the viral cellular immunity".

Back to Latest frontpage

15 May 2024

Solutions

Disruptive solutions for different sectors and use cases.

Hyris System™

The first multi-market platform able to deliver real value for the final customer, in a marketplace approach.

Partners

Hyris System™ allows a wide range of operators and researchers to develop their own assays and kits.

About Us

Hyris is a tech-bio company committed to democratise genetics and health insights.

Hyris signs a distribution agreement with GrowBIGogh

Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine

Hyris signs a distribution agreement with GrowBIGogh

Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine

Hyris' Solutions

Disruptive solutions for different sectors and use cases.

Hyris' Solutions

Disruptive solutions for different sectors and use cases.

Hyris System™

The first multi-market platform able to deliver real value for the final customer, in a marketplace approach.

Hyris System™

The first multi-market platform able to deliver real value for the final customer, in a marketplace approach.

Hyris Partners

Hyris System™ allows a wide range of operators and researchers to develop their own assays and kits.

Hyris Partners

Hyris System™ allows a wide range of operators and researchers to develop their own assays and kits.

Latest from Hyris

Discover Hyris recent stories, announcements, news, and much more.

Latests from Hyris

Discover Hyris recent stories, announcements, news, and much more.

About Us

Hyris is a tech-bio company committed to democratise genetics and health insights.

About Us

Hyris is a tech-bio company committed to democratise genetics and health insights.

Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia

Hyris signs a distribution agreement with GrowBIGogh

Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine

Hyris' signed a binding agreement for a reverse take-over, leading to a new integrated entity with Ulisse Biomed

Hyris' new onboarding programs support researchers and developers to launch testing kits.

Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson

Hyris and Singlabs signed a distributorship agreement for Singapore

Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.

Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine

Hyris signs a distribution agreement with GrowBIGogh

Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine

Hyris' signed a binding agreement for a reverse take-over, leading to a new integrated entity with Ulisse Biomed

Hyris' new onboarding programs support researchers and developers to launch testing kits.

Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson

Hyris and Singlabs signed a distributorship agreement for Singapore

Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.

Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine

Disruptive solutions
for different sectors and use cases.

Disruptive solutions
for different sectors
and use cases.

Disruptive solutions
for different sectors
and use cases.

The first multi-market platform
able to deliver real value
for the final customer,
in a marketplace approach.

The first multi-market platform
able to deliver real value
for the final customer,
in a marketplace approach.

Hyris System™ allows a wide range
of operators and researchers
to develop their own assays and kits.

Hyris System™ allows a wide range
of operators and researchers
to develop their own assays and kits.

Hyris is a tech-bio company
committed to democratise genetics
and health insights.

Hyris is a tech-bio company
committed to democratise genetics
and health insights.